Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Submitted by
admin
on March 27, 2011 - 11:39am
Source:
Seeking Alpha
News Tags:
ipilimumab
monoclonal antibodies
immunotherapy
Yervoy
Bristol-Myers Squibb
melanoma
Headline:
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Do Not Allow Advertisers to Use My Personal information
